Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells

Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms

(2014) Neha Bhagwat et al.   BLOOD

Targeting the BRCA1/2 Tumor Suppressors

(2014) Eliot Rosen et al.   CURRENT DRUG TARGETS

The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing

(2014) Y Liu et al.   LEUKEMIA

Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma

(2013) Fabiola Cervantes-Gomez et al.   Clinical Lymphoma Myeloma & Leukemia

Tumor burden in Hodgkin's lymphoma: Much more than the best prognostic factor

(2013) Paolo G. Gobbi   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

(2013) Prithviraj Bose et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

ATM signalling and cancer

(2013) C A Cremona et al.   ONCOGENE

WEE1 tyrosine kinase, a novel epigenetic modifier

(2013) Kiran Mahajan et al.   TRENDS IN GENETICS

Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management

(2012) Stephen M. Ansell   AMERICAN JOURNAL OF HEMATOLOGY

Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs

(2012) Christopher T. Saunders et al.   BIOINFORMATICS

STAR: ultrafast universal RNA-seq aligner

(2012) Alexander Dobin et al.   BIOINFORMATICS

Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma

(2012) Q. Yang et al.   BLOOD

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma

(2012) E. Tiacci et al.   BLOOD

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

(2012) H. Thorvaldsdottir et al.   BRIEFINGS IN BIOINFORMATICS

Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition

(2012) Martina Cozzi et al.   CELL CYCLE

Phosphorylation by cyclin-dependent kinase-9 controls ubiquitin-conjugating enzyme-2A function

(2012) Andrei Shchebet et al.   CELL CYCLE

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

(2012) Suzanne L Topalian et al.   CURRENT OPINION IN IMMUNOLOGY

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff

(2012) Pablo Cingolani et al.   FLY

Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma

(2011) Madhavi Challa-Malladi et al.   CANCER CELL

Mutation of NIMA-related kinase 1 (NEK1) leads to chromosome instability

(2011) Yumay Chen et al.   Molecular Cancer

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

(2011) Christian Steidl et al.   NATURE

Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances

(2011) Enrico Derenzini et al.   Genome Medicine

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

(2010) C. Steidl et al.   BLOOD

Toward a Personalized Treatment of Hodgkin's Disease

(2010) Vincent T. DeVita et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Sequence Alignment/Map format and SAMtools

(2009) H. Li et al.   BIOINFORMATICS

Fast and accurate short read alignment with Burrows-Wheeler transform

(2009) H. Li et al.   BIOINFORMATICS

Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells

(2009) L. S. Chen et al.   BLOOD

cIAP2 as a therapeutic target in colorectal cancer and other malignancies

(2009) Koh Miura et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Mutations ofNFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases

(2009) Annette Lake et al.   INTERNATIONAL JOURNAL OF CANCER

TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

(2009) Roland Schmitz et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Frequent inactivation of A20 in B-cell lymphomas

(2009) Motohiro Kato et al.   NATURE

Standard therapy of advanced Hodgkin lymphoma

(2009) J. Kuruvilla   Hematology-American Society of Hematology Education Program

Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization

(2008) S. Hartmann et al.   HAEMATOLOGICA

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

(2008) A. Tzankov et al.   HAEMATOLOGICA